Scientific article
English

Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance

Published inBritish journal of clinical pharmacology, vol. 78, no. 1, p. 135-144
Publication date2014
Abstract

A large interindividual variability in plasma concentrations has been reported in patients treated with donepezil, the most frequently prescribed antidementia drug. We aimed to evaluate clinical and genetic factors influencing donepezil disposition in a patient population recruited from a naturalistic setting.

Citation (ISO format)
NOETZLI, Muriel et al. Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance. In: British journal of clinical pharmacology, 2014, vol. 78, n° 1, p. 135–144. doi: 10.1111/bcp.12325
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0306-5251
517views
0downloads

Technical informations

Creation27/09/2015 12:47:00
First validation27/09/2015 12:47:00
Update time15/03/2023 00:48:55
Status update15/03/2023 00:48:54
Last indexation31/10/2024 02:52:06
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack